Grippe A (H1N1) et SDRA : caractéristiques des patients admis en réanimation et prise en charge. Revue de la littérature

Jaber, Samir; Conseil, Matthieu; Coisel, Y.; Jung, Boris; Chanques, Gérald

doi:10.1016/j.annfar.2009.12.026

Cited by 36 publications

(16 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Indeed, such efforts have been largely justified by the substantial risk of death even in young and apparently healthy subjects developing fulminant ARDS [1,20]. Given these premises, the application of current state-of-the-art ECMO technologies has been proposed as a promising means to reduce the morbidity and mortality of ARDS, complicating suspected or confirmed H1N1 influenza [2,21].…”

Section: Discussionmentioning

confidence: 99%

“…Use of a sample size cut-off was chosen pre hoc to limit the undue influence of anecdotal cases and the ensuing risk of imprecision and publication bias, in keeping with prior systematic reviews on H1N1 infection [1,2]. …”

Section: Methodsmentioning

confidence: 99%

“…H1N1 influenza has been the focus of substantial research given its higher case fatality among younger subjects and the potential for fulminant acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) [1]. In light of observational and randomized trials in support of extracorporeal membrane oxygenation (ECMO), this approach has been advocated for and employed in several cases of complicated H1N1 infection [2].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO

Zangrillo¹,

Biondi‐Zoccai

Landoni³

et al. 2013

Critical Care

237

231

View full text Add to dashboard Cite

IntroductionH1N1 influenza can cause severe acute lung injury (ALI). Extracorporeal membrane oxygenation (ECMO) can support gas exchange in patients failing conventional mechanical ventilation, but its role is still controversial. We conducted a systematic review and meta-analysis on ECMO for H1N1-associated ALI.MethodsCENTRAL, Google Scholar, MEDLINE/PubMed and Scopus (updated 2 January 2012) were systematically searched. Studies reporting on 10 or more patients with H1N1 infection treated with ECMO were included. Baseline, procedural, outcome and validity data were systematically appraised and pooled, when appropriate, with random-effect methods.ResultsFrom 1,196 initial citations, 8 studies were selected, including 1,357 patients with confirmed/suspected H1N1 infection requiring intensive care unit admission, 266 (20%) of whom were treated with ECMO. Patients had a median Sequential Organ Failure Assessment (SOFA) score of 9, and had received mechanical ventilation before ECMO implementation for a median of two days. ECMO was implanted before inter-hospital patient transfer in 72% of cases and in most patients (94%) the veno-venous configuration was used. ECMO was maintained for a median of 10 days. Outcomes were highly variable among the included studies, with in-hospital or short-term mortality ranging between 8% and 65%, mainly depending on baseline patient features. Random-effect pooled estimates suggested an overall in-hospital mortality of 28% (95% confidence interval 18% to 37%; I2 = 64%).ConclusionsECMO is feasible and effective in patients with ALI due to H1N1 infection. Despite this, prolonged support (more than one week) is required in most cases, and subjects with severe comorbidities or multiorgan failure remain at high risk of in-hospital death.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO

Zangrillo¹,

Biondi‐Zoccai

Landoni³

et al. 2013

Critical Care

237

231

View full text Add to dashboard Cite

show abstract

“…In the aftermath of the pandemic (H1N1) 2009, much attention has been focused on the respiratory manifestations of H1N1 (3, 4). Influenza is a major cause of acute respiratory tract illnesses each winter.…”

Section: Introductionmentioning

confidence: 99%

Neurologic Complications and Outcomes of Pandemic (H1N1) 2009 in Korean Children

et al. 2012

View full text Add to dashboard Cite

Neurologic complications of children with influenza A H1N1 2009 pandemic, diagnosed in two consecutive influenza seasons were retrospectively reviewed to seek better outcomes in future outbreaks. Patient demographics, clinical manifestations and neurologic outcomes were reviewed. A total of 1,389 children were diagnosed with influenza A H1N1 by real-time reverse transcriptase-polymerase chain reaction. Of these, 23 (1.7%) patients had neurologic involvement. Their mean age was 5.9 ± 3.6 yr (range, 6 months to 11 yr) and 16 (69.9%) were boys. None of the 23 patients had been vaccinated for influenza A H1N1 and seasonal influenzas. Twenty-two of the 23 patients presented with seizures. Clinical features included febrile convulsion (n = 19), afebrile convulsion (n = 1), aseptic meningitis (n = 1), encephalopathy (n = 1), and acute necrotizing encephalopathy (n = 1). They all were treated with Oseltamivir twice daily for 5 days immediately after nasal and throat swab testing. Twenty-one of the subjects recovered fully, but the youngest two infants experienced severe neurological sequelae. The results indicate that neurologic complications associated with influenza A H1N1 2009 pandemic were mostly mild, but rarely were serious. Prompt intervention leads to a better outcome and vaccination may prevent the disease, thus staving off serious neurological complications following influenza, especially in young infants.

show abstract

“…Некоторые признаки ОРДС (РДСВ) мы наблюдали у пациентов, включенных в данное исследование. На вероятность ОРДС могло указывать наличие катаральных явле-ний со стороны верхних дыхательных путей с перво-го дня болезни или появлении новых респираторных симптомов в пределах не более 7 дней от начала за- [19,20]. Этот клинический при-знак также наблюдался у пациентов основной груп-пы (рис.…”

Section: обсуждение результатов исследованияunclassified

Clinical analysis of the lethal outcomes at influenza, including A (H1N1) pdm09, in pandemic and post-pandemic period (2009–2016)

Градиль¹

2016

ScienceRise

View full text Add to dashboard Cite

Grippe A (H1N1) et SDRA : caractéristiques des patients admis en réanimation et prise en charge. Revue de la littérature

Cited by 36 publications

References 26 publications

Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO

Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO

Neurologic Complications and Outcomes of Pandemic (H1N1) 2009 in Korean Children

Clinical analysis of the lethal outcomes at influenza, including A (H1N1) pdm09, in pandemic and post-pandemic period (2009–2016)

Contact Info

Product

Resources

About